Participant consumed grapefruit or grapefruit products within 3 times before the first dose of study drug. - "Our study uncovered the crucial purpose from the KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, including OTX015 or ABBV-744, with DDP or gemcitabine https://irvingc332ozk5.ttblogs.com/profile